Navigation Links
U.S. FDA Approves Improved Performance of Riverain Medical's OnGuard Chest X-ray Computer-Aided Detection Technology
Date:6/21/2010

DAYTON, Ohio, June 21 /PRNewswire/ -- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard™ Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray (1). This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity compared to the original product (2).

(Logo: http://photos.prnewswire.com/prnh/20100325/CL76051LOGO-b )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100325/CL76051LOGO-b )

More than 200,000 Americans will be diagnosed with lung cancer this year. Only a small percentage of these patients will be diagnosed with lung cancer in the earliest stages when it is most treatable. When lung cancer is detected early, five-year survival rates triple (3). Multiple studies demonstrate that OnGuard can detect 37-50% of lung cancers that were missed in the initial interpretation (4),(5).

"Our published studies demonstrate that OnGuard can detect up to 50% of the lung cancers that were missed in the initial interpretation," says Dr. Charles White, Professor and Vice Chairman of Radiology at the University of Maryland School of Medicine. "OnGuard provides physicians with a tool to help identify suspicious nodules in the lungs earlier."

OnGuard uses pattern recognition and machine learning technology to detect nodules. Well centered, scaled markers are then placed around regions of interest that may be early-stage lung cancer. Because OnGuard utilizes the existing digital chest X-ray, there is no additional radiation dose, patient procedure, hardware or stand-alone workstation needed to integrate the technology into any radiology department.

"OnGuard can make a difference in the fight against lung cancer," explains Diane Hirakawa, CEO and Chairman of Riverain Medical. "This technology can improve the detection of lung cancer in its earliest stages when treatments are most effective."

About Riverain Medical

Dayton, Ohio based medical technology innovator Riverain Medical develops practical solutions to save and improve the quality of people's lives, through the early detection of disease. The company's technologies are designed to enhance the expert skills of physicians to improve patient outcomes without additional radiation dose or procedures.

(1) http://lungcancer.about.com/od/typesoflungcancer/a/spn.htm

(2) Riverain Medical Clinical Trial for U.S. FDA Submission

(3) American Cancer Society Facts and Figures 2010

(4) C. White, T. Flukinger, J. Jeudy and J. Chen (2009). Use of a Computer-Aided Detection System to Detect Missed Lung Cancer at Chest Radiography. Radiology. 252: 273-281.

(5) F. Li, R. Englemann, C. Metz, K. Doi and H. MacMahon (2008). Lung Cancers Missed on Chest Radiographs:  Results Obtained with a Commercial Computer-aided Detection Program. Radiology. 246: 273-280.


'/>"/>
SOURCE Riverain Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
2. FDA Approves New Treatment for Late-Onset Pompe Disease
3. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
4. U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
5. FDA Approves New Combination Product Oral Contraceptive
6. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
7. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
8. FDA Approves New Device for Adults with Severe and Persistent Asthma
9. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
10. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
11. FDA Approves First Totally Implanted Hearing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Ischemic Stroke Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Ischemic Stroke Market and Competitive Landscape Highlights ... Stroke pipeline products, Acute Ischemic Stroke epidemiology, ...
(Date:5/3/2016)... PUNE, India , May 4, 2016 /PRNewswire/ ... report spreads across 154 pages, profiling 09 key ... It is a professional and in-depth study on ... providing a basic overview of the industry including ... Insulin Needles market analysis is provided for the ...
(Date:5/3/2016)... Ariz. , May 3, 2016  As a ... twice contracted rheumatic fever, which damaged his heart. He ... But by June 2013, Shepherd,s heart was giving ... from death. On June 20, 2013, the ... Total Artificial Heart (TAH-t). Like a heart transplant, the ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National ... encouraging people all over the United States to thank a nurse who's made a ... will donate $5 to the American Red Cross of San Diego/Imperial Counties (up to ...
(Date:5/5/2016)... Boston, MA (PRWEB) , ... May 05, 2016 , ... ... stress becomes a constant presence, it can weaken the immune system and increase inflammation, ... Ami B. Bhatt, director of the adult congenital heart disease program at Harvard-affiliated Massachusetts ...
(Date:5/5/2016)... ... May 05, 2016 , ... CURE Media Group ... today announced a new collaboration with Imerman Angels to expand outreach and ... the world. , “Imerman Angels provides an emotional lifeline to patients and families facing ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dermatologic surgeons performed nearly 10 ... and up 27 percent since 2012. , The results of the 2015 ASDS Survey ... increase in skin cancer treatments and the growing popularity of soft-tissue fillers and body ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Liposuction specialist Marcia ... Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. This year’s ... chosen to address the conference about her unique specialization in treating Lipedema. Dr. Byrd ...
Breaking Medicine News(10 mins):